Paul T Quinlan
General Counsel · 6 filings · Latest: Sep 21, 2026
Oruka Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ORKA | Paul T Quinlan | General Counsel | Sep 21, 2026 | Sale | $93.64 | 10,000 | $936.4K | 29,995 | |
ORKA | Paul T Quinlan | General Counsel | Sep 21, 2026 | Option Exercise | $7.80 | 10,000 | $78.0K | 39,995 | |
ORKA | Paul T Quinlan | General Counsel | Sep 15, 2026 | Sale | $95.71 | 1,039 | $99.4K | 29,995 | |
ORKA | Paul T Quinlan | General Counsel | Aug 14, 2026 | Sale | $108.49 | 52,000 | $5.6M | 31,034 | |
ORKA | Paul T Quinlan | General Counsel | Aug 14, 2026 | Option Exercise | $11.60 | 52,000 | $603.0K | 83,034 | |
ORKA | PAUL QUINLAN | — | Aug 14, 2026 | Proposed Sale | $108.12 | 71,000 | $7.7M | — | |
ORKA | Paul T Quinlan | General Counsel | Jun 15, 2026 | Sale | $69.69 | 733 | $51.1K | 31,034 | |
ORKA | Paul T Quinlan | General Counsel | Mar 16, 2026 | Sale | $41.30 | 733 | $30.3K | 31,767 |